Home›Companies›Biotech & Pharma›Zena Therapeutics

Zena Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 7, 2023·Suggest an edit

About Zena Therapeutics

Zena Therapeutics is a private company based in Princeton, New Jersey, incorporated in 2021 in Delaware. It has reported $500,000 raised in one offering on Form D since September 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 11, 2023Sep 7, 2023$500,000fully sold1$500KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Zena Therapeutics's Form D filed Sep 7, 2023.

EC
Eileen Carry
Chief Scientific Officer and director
AV
Ariane Vasilatis
Executive officer and director

Sources

  1. SECZena Therapeutics Inc. filing history